IL1B and hyperlipidemia: With hyperlipidemia, fatty acids and cholesterol crystals increase, possibly activating the Nalp3-inflammasome and leading to increased release of IL-1β, one of the critical pro-inflammatory cytokines involved in the development and progression of KOA28–30.